Business
QIMC Announces Closing of $17.3 Million Bought Deal Offering, Including Full Exercise of Underwriter's Over-Allotment Option
Vancouver, British Columbia and Montreal, Quebec--(Newsfile Corp. - April 27, 2026) - Québec Innovative Materials Corp. (CSE: QIMC) (OTCQB: QIMCF) (FSE: 7FJ) ("QIMC" or the "Company") is pleased to announce that it has completed its previously announced "bought deal" private placement offering (the "Offering") pursuant to which the Company issued 19,167,050 units of the Company (each, a "Unit") at a price of C$0.90 per Unit (the "Issue Price") for aggregate gross proceeds of C$17,250,345...
About this update from Quebec Innovative Materials Corp
[{"type":"text","content":"Vancouver, British Columbia and Montreal, Quebec--(Newsfile Corp. - April 27, 2026) - Québec Innovative Materials Corp. (CSE: QIMC) (OTCQB: QIMCF) (FSE: 7FJ) ("QIMC" or the "Company") is pleased to announce that it has completed its previously announced "bought deal" private placement offering (the "Offering") pursuant to which the Company issued 19,167,050 units of the Company (each, a "Unit") at a price of C$0.90 per Unit (the "Issue Price") for aggregate gross proceeds of C$17,250,345 including the full exercise of the Underwriter's (as defined herein) over-allotment option. The Offering was led by Research Capital Corporation as the sole underwriter and sole bookrunner (the "Underwriter").","length":776,"tagName":"p"},{"type":"text","content":"Each Unit consists of one common share of the Company (each, a "Common Share") and one Common Share purchase warrant (each, a "Warrant"). Each Warrant entitles the holder to purchase one Common Share of the Company at an exercise price of C$1.30 at any time until April 27, 2029, subject to adjustment in certain circumstances.","length":347,"tagName":"p"},{"type":"text","content":"The Company intends to use the net proceeds from the Offering for exploration and evaluation of the Company's existing hydrogen and helium projects and for general working capital purposes.","length":193,"tagName":"p"},{"type":"text","content":"The Units were issued pursuant to the listed issuer financing exemption under Part 5A of National Instrument 45-106 – Prospectus Exemptions, as amended by CSA Coordinated Blanket Order 45-935 – Exemptions from Certain Conditions of the Listed Issuer Financing Exemption (collectively, the "Listed Issuer Financing Exemption"), in all provinces of Canada, except Quebec, and other qualifying jurisdictions outside of Canada, including the United States, on a private placement basis pursuant to relevant prospectus or registration exemptions in accordance with applicable laws. The Units issued to subscribers under the Listed Issuer Financing Exemption will be immediately "free-trading" under applicable Canadian securities laws. All other securities not issued pursuant to the Listed Issuer Financing Exemption, including the Broker Warrants (a...